DGI:ZNS-Infektionen/Nosokomiale Ventrikulitis und Meningitis/Weiterführende Literatur und Hilfestellungen: Difference between revisions

From Infektiopedia
imported>Bestem
imported>Bestem
No edit summary
 
(3 intermediate revisions by 3 users not shown)
Line 1: Line 1:
==<span class="ve-pasteProtect" style="font-size:18.0pt; mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:Calibri; mso-bidi-theme-font:minor-latin;mso-ansi-language:DE" data-ve-attributes="{&quot;style&quot;:&quot;font-size:18.0pt;\nmso-fareast-font-family:\&quot;Times New Roman\&quot;;mso-bidi-font-family:Calibri;\nmso-bidi-theme-font:minor-latin;mso-ansi-language:DE&quot;}">Weiterführende Literatur & Hilfestellungen</span>==
 
<span class="ve-pasteProtect" style="font-size:12.0pt;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:
Eine Übersicht über die typische Penetration von Antiinfektiva über die Blut-Hirn-Schranke (mit/ohne meningeale Infektion) sowie pathophysiologische Grundlagen haben Nau et al. publiziert<ref><span style="color: #333333">Nau R, Seele J, Djukic M, Eiffert H: Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections. Curr Opin Infect Dis 2018; 31(1):57-68</span></ref><ref><span style="color: #333333">Nau R, Sorgel F, Eiffert H: Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010; 23(4):858-883</span></ref><ref><span style="color: #333333">Nau R, Sorgel F, Prange HW: Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998; 35(3):223-246</span></ref>.
Calibri;mso-bidi-theme-font:minor-latin;mso-ansi-language:DE" data-ve-attributes="{&quot;style&quot;:&quot;font-size:12.0pt;mso-fareast-font-family:\&quot;Times New Roman\&quot;;mso-bidi-font-family:\nCalibri;mso-bidi-theme-font:minor-latin;mso-ansi-language:DE&quot;}">Eine Übersicht über die typische Penetration von Antiinfektiva über die Blut-Hirn-Schranke (mit/ohne meningeale Infektion) sowie pathophysiologische Grundlagen haben Nau et al. publiziert <span class="ve-pasteProtect" style="mso-no-proof:yes" data-ve-attributes="{&quot;style&quot;:&quot;mso-no-proof:yes&quot;}">[34-36</span></span><ref><span style="color: #333333">34. <span class="ve-pasteprotect"><span data-ve-attributes="{&quot;style&quot;:&quot;mso-tab-count:1&quot;}" style="box-sizing: inherit">          <span style="box-sizing: inherit"> </span></span></span>Nau R, Seele J, Djukic M, Eiffert H: Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections. Curr Opin Infect Dis 2018; 31(1):57-68</span></ref><ref><span style="color: #333333">35. <span class="ve-pasteprotect"><span data-ve-attributes="{&quot;style&quot;:&quot;mso-tab-count:1&quot;}" style="box-sizing: inherit">          <span style="box-sizing: inherit"> </span></span></span>Nau R, Sorgel F, Eiffert H: Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010; 23(4):858-883</span></ref><ref><span style="color: #333333">36. <span class="ve-pasteprotect"><span data-ve-attributes="{&quot;style&quot;:&quot;mso-tab-count:1&quot;}" style="box-sizing: inherit">          <span style="box-sizing: inherit"> </span></span></span>Nau R, Sorgel F, Prange HW: Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998; 35(3):223-246</span></ref><span class="ve-pasteProtect" style="font-size:12.0pt;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;mso-ansi-language:DE" data-ve-attributes="{&quot;style&quot;:&quot;font-size:12.0pt;mso-fareast-font-family:\&quot;Times New Roman\&quot;;mso-bidi-font-family:\nCalibri;mso-bidi-theme-font:minor-latin;mso-ansi-language:DE&quot;}"><span class="ve-pasteProtect" style="mso-no-proof:yes" data-ve-attributes="{&quot;style&quot;:&quot;mso-no-proof:yes&quot;}">]</span></span><span class="ve-pasteProtect" style="font-size:12.0pt;mso-fareast-font-family:
&quot;Times New Roman&quot;;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;
mso-ansi-language:DE" data-ve-attributes="{&quot;style&quot;:&quot;font-size:12.0pt;mso-fareast-font-family:\n\&quot;Times New Roman\&quot;;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;\nmso-ansi-language:DE&quot;}">.</span>
<br />

Latest revision as of 16:23, 9 September 2021

Eine Übersicht über die typische Penetration von Antiinfektiva über die Blut-Hirn-Schranke (mit/ohne meningeale Infektion) sowie pathophysiologische Grundlagen haben Nau et al. publiziert[1][2][3].

  1. ↑ Nau R, Seele J, Djukic M, Eiffert H: Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections. Curr Opin Infect Dis 2018; 31(1):57-68
  2. ↑ Nau R, Sorgel F, Eiffert H: Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010; 23(4):858-883
  3. ↑ Nau R, Sorgel F, Prange HW: Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998; 35(3):223-246
Retrieved from "https://wiki.cakele.iodatalabs.dev/index.php?title=DGI:ZNS-Infektionen/Nosokomiale_Ventrikulitis_und_Meningitis/Weiterführende_Literatur_und_Hilfestellungen&oldid=2577"